Meridian Bioscience, Inc. Reports Record Fiscal 2006 Operating Results, Increases Regular Cash Dividend Rate, And Reaffirms Guidance

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ:VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported record fiscal 2006 net sales of $108.4 million and record diluted earnings per share of $0.68, respective increases of 17% and 31% over the prior fiscal year;